D'ADDATO, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 10.892
AS - Asia 8.117
EU - Europa 7.956
SA - Sud America 717
Continente sconosciuto - Info sul continente non disponibili 473
AF - Africa 374
OC - Oceania 13
Totale 28.542
Nazione #
US - Stati Uniti d'America 10.659
IT - Italia 3.694
CN - Cina 2.236
SG - Singapore 2.164
VN - Vietnam 1.870
GB - Regno Unito 1.316
DE - Germania 663
SE - Svezia 531
HK - Hong Kong 488
BR - Brasile 483
FR - Francia 385
IN - India 358
RU - Federazione Russa 280
KR - Corea 267
UA - Ucraina 243
BD - Bangladesh 215
NL - Olanda 192
IE - Irlanda 181
JP - Giappone 148
ZA - Sudafrica 123
CA - Canada 110
CI - Costa d'Avorio 102
EE - Estonia 100
TG - Togo 81
AR - Argentina 76
FI - Finlandia 61
PL - Polonia 60
JO - Giordania 55
CH - Svizzera 46
MX - Messico 46
PE - Perù 41
ES - Italia 40
ID - Indonesia 40
IQ - Iraq 40
EC - Ecuador 32
SA - Arabia Saudita 32
PH - Filippine 31
TR - Turchia 28
TH - Thailandia 27
AT - Austria 26
CO - Colombia 26
BG - Bulgaria 25
BE - Belgio 23
GR - Grecia 23
SC - Seychelles 21
VE - Venezuela 21
PK - Pakistan 17
CL - Cile 16
JM - Giamaica 15
MY - Malesia 13
PY - Paraguay 13
TW - Taiwan 13
AU - Australia 12
CR - Costa Rica 12
AL - Albania 10
DZ - Algeria 10
RO - Romania 10
TT - Trinidad e Tobago 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
RS - Serbia 8
TN - Tunisia 8
EG - Egitto 7
IR - Iran 7
LB - Libano 7
NP - Nepal 7
HN - Honduras 6
HR - Croazia 6
IL - Israele 6
NI - Nicaragua 6
SV - El Salvador 6
CZ - Repubblica Ceca 5
GT - Guatemala 5
KE - Kenya 5
LU - Lussemburgo 5
BO - Bolivia 4
EU - Europa 4
LT - Lituania 4
LV - Lettonia 4
MA - Marocco 4
NG - Nigeria 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AZ - Azerbaigian 3
BB - Barbados 3
BY - Bielorussia 3
CY - Cipro 3
KZ - Kazakistan 3
PR - Porto Rico 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
CM - Camerun 2
DO - Repubblica Dominicana 2
MQ - Martinica 2
QA - Qatar 2
SI - Slovenia 2
TJ - Tagikistan 2
AM - Armenia 1
AO - Angola 1
Totale 28.046
Città #
Singapore 1.484
Southend 1.127
Ashburn 802
San Jose 729
Hefei 634
Fairfield 587
Santa Clara 544
Hong Kong 463
Chandler 416
Dong Ket 399
Ho Chi Minh City 372
Council Bluffs 349
Bologna 340
Milan 305
Hanoi 298
Woodbridge 272
Wilmington 271
Princeton 265
Houston 262
Seattle 261
Beijing 243
Seoul 238
Rome 220
Cambridge 213
Los Angeles 187
Dublin 179
New York 179
Boardman 178
Ann Arbor 176
Lauterbourg 154
Jacksonville 151
Turin 135
Tokyo 125
Dallas 123
Nanjing 118
Padova 115
Westminster 109
Abidjan 102
Naples 87
Buffalo 85
Berlin 83
Lomé 81
São Paulo 80
Bremen 73
Atlanta 63
Haiphong 57
Saint Petersburg 56
Amman 53
Bengaluru 53
Medford 53
Chicago 52
Shanghai 51
Jinan 50
Phoenix 48
San Diego 47
San Francisco 47
Helsinki 45
Palermo 43
Shenyang 42
Verona 42
Warsaw 42
Redondo Beach 41
Florence 40
Nanchang 39
Lima 36
Modena 36
Hebei 35
The Dalles 34
Da Nang 33
Dearborn 33
London 32
Bari 31
Guangzhou 31
Parma 31
Frankfurt am Main 30
Changsha 29
Denver 29
Redwood City 28
Amsterdam 26
Brooklyn 26
Mülheim 25
Des Moines 24
Montreal 24
Sofia 24
Toronto 24
Zhengzhou 23
Catania 22
Genoa 22
Nuremberg 22
Redmond 22
Rimini 22
Bern 21
Hải Dương 21
Orem 21
Norwalk 20
Chengdu 19
Falls Church 19
Biên Hòa 18
Brussels 18
Can Tho 18
Totale 15.507
Nome #
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 1.767
Lo studio Brisighella: 40 anni di ricerca nella prevenzione delle malattie cardiovascolari. 1.307
Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus® and placebo 1.300
Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209 527
Subjective effects of a combined lipid-lowering nutraceutical or ezetimibe on well-being and sexual performance in patients with perceived worsening of erectile function during statin treatment: a randomised clinical trial 344
Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial 340
Is the 2020 Sampson equation the best formula for LDL-C estimation? 317
A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels 286
Prevalent seasoning and cooking fats, arterial stiffness and lipid pattern in a rural population sample: data from the Brisighella Heart Study 231
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 224
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 221
Observation of possibly relations between trend of CPK levels and LDL cholesterol in patients with hypercholesterolemia and asymptomatic primary high level of creatinechinase under statin therapy 216
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study 216
Relationship between lipid phenotypes, overweight, lipid lowering drug response and KIF6 and HMG-CoA genotypes in a subset of the brisighella heart study population 215
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 215
Prevalenza e determinati clinico-laboratoristici della sindrome metabolica in un campione di soggetti in età geriatrica: il Brisighella Heart Study 209
Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: A three-arm, double-blind, randomized clinical trial 207
Relazione tra livelli sierici di acido urico e rigidità arteriosa in un campione di adulti-anziani: i dati del Brisighella Heart Study 202
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 201
Epidemiologia della sindrome metabolica nel Brisighella heart study 201
1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT 199
Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: data from the Brisighella Heart Study 199
Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. 198
A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease 193
Arterial stiffness, sugar-sweetened beverages and fruits intake in a rural population sample: Data from the brisighella heart study 191
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 189
Prevalence of metabolic syndrome in working population: preliminary results fo a campaign of cardiovascular risk screening 188
High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects 187
Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study 185
Brisighella Heart Study: metabolic syndrome in a borderline area. 181
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 181
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 180
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: A randomized, double-blind, placebo controlled study 179
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 177
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study 175
Efficacia della supplementazione dietetice con fibre solubili nelle gestione del rischio delle malattie cardiovascolari di pazienti affetti da SM: un trial clinico randomizzato open label di un anno 174
Cardiovascular mortality and physical activity in a rural population: the Brisighella Study. 174
METABOLIC SYNDROME IN EUROPEAN RURAL POPULATION-DATA FROM THE BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA) 170
Association between not HDL cholesterol levels and hypertension in the Brisighella Hart Study. 169
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 169
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study 167
Correction to: Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: A three-arm, double-blind, randomized clinical trial (Nutrition and Metabolism (2017) 14 (61) DOI: 10.1186/s12986-017-0214-2) 167
L'attività fisica durante il tempo libero e la mortalità per malattie cardiovascolari: i dati del Brisighella Heart Study. 167
Farmaci ipocolesterolemizzanti. 166
Brisghella Heart Study (BHS): controllo dei valori pressori dal 1984 al 2004. 166
2B02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE: DATA FROM THE BRISIGHELLA HEART STUDY 164
Osservazioni clinico sperimentali su possibili relazioni tra andamento dei valori sierici di creatinina kinasi e colesterolo LDL in pazienti asintomatici con ipercoelsterolemia ed elevati livelli di CPK in corso di terapia con statine. 163
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study 163
Iperlipoproteinemia familiare combinata: complicanze cardiovascolari e cerebrovascolari 161
Brisghella Heart Study (BHS): hypertension and obesity. 160
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor 160
From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study 157
A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO ®) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study) 155
Short- and Long-Term Stroke Risk after Urgent Management of Transient Ischaemic Attack: The Bologna TIA Clinical Pathway 154
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 152
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 152
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study 152
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 152
Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study 152
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study 150
Physical activity and cardiovascular disease mortality: the Brisighella heart study 149
Relazione tra pressione arteriosa, colesterolemia ed apolipoproteina B in un campione di popolazione di grandi dimensioni: il Brisighella Heaat Study. 149
Attività fisica e aterosclerosi: i dati di Brisghella 149
Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial 149
Healthy Eating beyond Whole Grains—Insight on Associations between Diet Quality and Arterial Stiffness in the Brisighella Heart Study Cohort 148
Confronto di due algoritmi diagnostici nella strima della prevalenza della sindrome metabolica in soggetti in età geriatrica e nella popolazione gnerale: Il Brisighella Heart Study. 147
Severe hypercholesterolaemia in a paediatric patient with congenital analbuminaemia 147
LDL-oxidation, serum uric acid and pulse-wave velocity relationship in chronic kidney disease: Data from the Brisighella heart study cohort 146
Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population. 146
Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study. 144
Main predictors of metabolic syndrome and type 2 diabetes development in the historical cohort of the Brisighella Heart Study: a 16 years follow-up. 144
Cardiovascular risk in patients with metabolic syndrome enrolled in the Brisighella Heart Study. 144
How important are triglycerides as risk factors? 143
The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study 142
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study 142
SERUM URIC ACID CHANGE AND MODIFICATION OF BLOOD PRESSURE AND FASTING PLASMA GLUCOSE IN A PHARMACOLOGICALLY UNTREATED POPOLATION SAMPLE: DATA FROM THE BRISIGHELLA HEART STUDY 141
The Brisighella Heart Study: cardiovascular complications in subjects in subjects with metabolic syndrome. 141
Anlysis of lipid lowering treatment in patients at high cardiovascular risk discharged from S.Orsola-Malpighi Hospital, Bologna. 140
Serum uric acid and markers of low-density lipoprotein oxidation in nonsmoking healthy subjects: data from the Brisighella Heart Study. 140
Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic 140
EFFECT OF SPONTANEOUS CHANGES IN DIETARY COMPONENTS AND SERUM LIPOPROTEIN(A): DATA FROM THE BRISIGHELLA HEART STUDY 139
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 137
Modification of the dietary habits in the Brisighella Heart Study 137
LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort 137
Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes (Cardiovascular Diabetology, (2022), 21, 1, (57), 10.1186/s12933-022-01495-8) 136
RELATIONSHIP BETWEEN SERUM URIC ACID AND METABOLIC SYNDROME IN THE BRISIGHELLA HEART STUDY COHORT 136
Brisghella Heart Study (BHS): ipertensione ed obesità. 136
Association between cigarette smoking and serum lipid levels in a italian cohort: the Brisighella Heart Study. 135
Laboratory and Instrumental Risk Factors Associated with a Sudden Cardiac Death Prone ECG Pattern in the General Population: Data from the Brisighella Heart Study 135
ADJUSTED NECK CIRCUMFERENCE AND METABOLIC SYNDROME: RESULTS FROM THE BRISIGHELLA HEART STUDY 132
La compromissione della funzione renale in un campione di popolazione generale: dati del Brisighella Heart Study. 132
CORRELATIONS BETWEEN SERUM THIOCYANATES AND HEART RISK FACTORS IN THE HISTORICAL BRISIGHELLA HEART STUDY COHORT 131
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting 131
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 131
null 131
Physical activity trend in a rural population submitted to a nutritional program: the Brisighella Heart Study 130
Relationship Between Serum Uric Acid and Electrocardiographic Alterations in a Large Sample of General Population: Data From the Brisighella Heart Study 129
Endothelial dysfunction evaluation by sub- and supra-anaerobic threshold (AT) VO2 kinetiks in contrast load exercises. 128
Plasma lipid effects of corn oil and extra-virgin olive oil in hypercholesterolemic subjects: a randomized, controlled trial. 128
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 125
Totale 21.131
Categoria #
all - tutte 69.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.793 0 0 0 95 231 161 40 186 118 110 493 359
2022/20232.687 255 347 137 335 166 161 126 174 449 142 282 113
2023/20241.247 51 160 72 106 104 104 99 101 76 140 90 144
2024/20254.144 194 564 299 293 811 235 313 166 142 127 242 758
2025/20268.497 715 997 879 706 827 481 677 443 1.283 643 387 459
2026/20273.893 1.179 723 1.090 901 0 0 0 0 0 0 0 0
Totale 28.542